Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Graves Kurt
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Biondi Paul
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fraser Claire
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ausiello Dennis A
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berenson Stephen
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kender Richard N
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dere Willard H
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Teresa L.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henn Matthew R.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shaff Eric D.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DesRosier Thomas
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer von Moltke Lisa
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thorell Marella
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Teresa L.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henn Matthew R.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shaff Eric D.
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer von Moltke Lisa
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DesRosier Thomas
Seres Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Woerle Hans-Juergen
Seres Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Woerle Hans-Juergen